JPWO2018067548A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2018067548A5 JPWO2018067548A5 JP2019538581A JP2019538581A JPWO2018067548A5 JP WO2018067548 A5 JPWO2018067548 A5 JP WO2018067548A5 JP 2019538581 A JP2019538581 A JP 2019538581A JP 2019538581 A JP2019538581 A JP 2019538581A JP WO2018067548 A5 JPWO2018067548 A5 JP WO2018067548A5
- Authority
- JP
- Japan
- Prior art keywords
- blockade
- mice
- week
- old
- cage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
実施例2
レパリキシンを用いたKC/CXCR2軸遮断は、db/dbマウスにおける尿アルブミン***(UAE)の増加を予防し、メサンギウム拡大を軽減する
DN進行におけるIL8遮断の潜在的役割を評価するために、7週齢のdb/dbマウスを18週間にわたって(25週齢まで)1日2回、15 mg/kg (ip)のレパリキシンで処置した。簡潔に述べると、動物を調光環境下自由摂水で代謝ケージ(Nalgene)中で飼育し、糞および尿を分離した。サンプル回収チューブは、調光環境の底の小孔を通してケージ下に回した。
Example 2
KC / CXCR biaxial blockade with reparixin prevents increased urinary albumin excretion (UAE) in db / db mice and reduces mesangial spread
To assess the potential role of IL8 blockade in DN progression, 7-week-old db / db mice were treated with 15 mg / kg (ip) repalixin twice daily (up to 25-week-old) for 18 weeks. .. Briefly, animals were housed in a metabolic cage (Nalgene) in a dimmed environment with free water intake and feces and urine were isolated. The sample collection tube was routed under the cage through a small hole at the bottom of the dimming environment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022197569A JP2023036680A (en) | 2016-10-03 | 2022-12-12 | Prevention and treatment of diabetic nephropathy |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662403368P | 2016-10-03 | 2016-10-03 | |
US62/403,368 | 2016-10-03 | ||
PCT/US2017/054916 WO2018067548A1 (en) | 2016-10-03 | 2017-10-03 | Prevention and treatment of diabetic nephropathy |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022197569A Division JP2023036680A (en) | 2016-10-03 | 2022-12-12 | Prevention and treatment of diabetic nephropathy |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2019534894A JP2019534894A (en) | 2019-12-05 |
JPWO2018067548A5 true JPWO2018067548A5 (en) | 2022-04-18 |
JP7252125B2 JP7252125B2 (en) | 2023-04-04 |
Family
ID=61831556
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019538581A Active JP7252125B2 (en) | 2016-10-03 | 2017-10-03 | Prevention and treatment of diabetic nephropathy |
JP2022197569A Withdrawn JP2023036680A (en) | 2016-10-03 | 2022-12-12 | Prevention and treatment of diabetic nephropathy |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022197569A Withdrawn JP2023036680A (en) | 2016-10-03 | 2022-12-12 | Prevention and treatment of diabetic nephropathy |
Country Status (8)
Country | Link |
---|---|
US (2) | US11291641B2 (en) |
EP (1) | EP3518898A4 (en) |
JP (2) | JP7252125B2 (en) |
CN (2) | CN109890364B (en) |
AU (1) | AU2017339942B2 (en) |
CA (1) | CA3037071A1 (en) |
IL (1) | IL265693B2 (en) |
WO (1) | WO2018067548A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022103924A1 (en) * | 2020-11-11 | 2022-05-19 | Northwestern University | Focal adhesion complex proteins as a diagnostic marker for podocytophathies |
EP4052702A1 (en) * | 2021-03-04 | 2022-09-07 | Dompé farmaceutici S.p.a. | Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizures |
EP4309641A1 (en) * | 2022-07-19 | 2024-01-24 | Dompe' Farmaceutici S.P.A. | Reparixin liquid suspensions |
EP4309645A1 (en) * | 2022-07-19 | 2024-01-24 | Dompe' Farmaceutici S.P.A. | Powder mixture comprising reparixin |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5326707A (en) | 1991-11-29 | 1994-07-05 | Miles Inc. | Composition and device for urinary protein assay and method of using the same |
US5492834A (en) | 1993-07-09 | 1996-02-20 | Beckman Instruments, Inc. | Method of sample preparation for urine protein analysis with capillary electrophoresis |
US6448379B1 (en) * | 1993-09-14 | 2002-09-10 | Chiron Corporation | IL8 inhibitors |
US5385847A (en) | 1993-12-02 | 1995-01-31 | Miles Inc. | Method for the determination of urinary protein and creatinine |
EP0809492A4 (en) * | 1995-02-17 | 2007-01-24 | Smithkline Beecham Corp | Il-8 receptor antagonists |
US20030027216A1 (en) | 2001-07-02 | 2003-02-06 | Kiernan Urban A. | Analysis of proteins from biological fluids using mass spectrometric immunoassay |
US5750405A (en) | 1996-03-01 | 1998-05-12 | Bayer Corporation | Method for the detection for protein |
CN1227555A (en) * | 1996-06-12 | 1999-09-01 | 日本烟草产业株式会社 | Cytokine production inhibitors triazepine compounds, and intermediates thereof |
US6133426A (en) | 1997-02-21 | 2000-10-17 | Genentech, Inc. | Humanized anti-IL-8 monoclonal antibodies |
AU1924699A (en) * | 1997-12-19 | 1999-07-12 | Smithkline Beecham Corporation | Compounds of heteroaryl substituted imidazole, their pharmaceutical compositionsand uses |
US6468532B1 (en) | 1998-01-22 | 2002-10-22 | Genentech, Inc. | Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates |
AU1918199A (en) * | 1998-02-23 | 1999-09-06 | Warner-Lambert Company | Substituted imidazo(1,2-a;3,4-a')diquinolinylium interleukin-8 receptor antagonists |
IT1303249B1 (en) | 1998-10-23 | 2000-11-06 | Dompe Spa | SOME N- (2-ARYL-PROPIONYL) -SULPHONAMIDS AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM. |
US7037916B2 (en) * | 1999-07-15 | 2006-05-02 | Pharmacopeia Drug Discovery, Inc. | Pyrimidine derivatives as IL-8 receptor antagonists |
WO2001079209A2 (en) * | 2000-04-13 | 2001-10-25 | Millennium Pharmaceuticals, Inc. | Diazafluorenone il-8 antagonists |
US20030232396A1 (en) | 2002-02-22 | 2003-12-18 | Biolife Solutions, Inc. | Method and use of protein microarray technology and proteomic analysis to determine efficacy of human and xenographic cell, tissue and organ transplant |
CA2487732C (en) * | 2002-05-28 | 2013-10-15 | Bette Pollard | Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders |
US20040229901A1 (en) * | 2003-02-24 | 2004-11-18 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist |
WO2005002416A2 (en) * | 2003-06-04 | 2005-01-13 | Joslin Diabetes Center, Inc. | Predictors of renal disease |
EP1776336B1 (en) | 2004-03-23 | 2009-09-30 | DOMPE' pha.r.ma s.p.a. | 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
US20060063836A1 (en) * | 2004-09-16 | 2006-03-23 | Roman Richard J | Method for treating renal disease |
MX2010010198A (en) * | 2008-03-20 | 2010-12-21 | Carolus Therapeutics Inc | Methods of treating inflammation. |
EP2166006A1 (en) | 2008-09-18 | 2010-03-24 | Dompe' S.P.A. | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
BRPI0921150B1 (en) | 2008-11-11 | 2022-05-10 | The Regents Of The University Of Michigan | Use of a cxcr1 antagonist for tumor treatment |
ES2706403T3 (en) * | 2008-12-10 | 2019-03-28 | Joslin Diabetes Center Inc | Methods to diagnose and predict kidney disease |
EP2308485A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides for the prevention of diabetes |
EP2308484A1 (en) * | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
US8440655B2 (en) | 2010-06-21 | 2013-05-14 | Theracos, Inc. | Combination therapy for the treatment of diabetes |
-
2017
- 2017-10-03 WO PCT/US2017/054916 patent/WO2018067548A1/en active Application Filing
- 2017-10-03 CN CN201780061270.5A patent/CN109890364B/en active Active
- 2017-10-03 CN CN202311227778.1A patent/CN117503933A/en active Pending
- 2017-10-03 US US16/338,834 patent/US11291641B2/en active Active
- 2017-10-03 AU AU2017339942A patent/AU2017339942B2/en active Active
- 2017-10-03 JP JP2019538581A patent/JP7252125B2/en active Active
- 2017-10-03 CA CA3037071A patent/CA3037071A1/en active Pending
- 2017-10-03 EP EP17859008.9A patent/EP3518898A4/en active Pending
-
2019
- 2019-03-28 IL IL265693A patent/IL265693B2/en unknown
-
2022
- 2022-02-24 US US17/679,842 patent/US20220184009A1/en active Pending
- 2022-12-12 JP JP2022197569A patent/JP2023036680A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2018067548A5 (en) | ||
Wang et al. | Prevalence and molecular characterization of Cryptosporidium spp. and Giardia duodenalis in 1–2-month-old highland yaks in Qinghai Province, China | |
Khodakaram Tafti et al. | Pathologic lesions of naturally occurring coccidiosis in sheep and goats | |
Williams et al. | Mustelids | |
Rubenstein et al. | Environmental and hormonal correlates of immune activity in a cooperatively breeding tropical bird | |
Giachini Tosetto et al. | Thaliacean community responses to distinct thermohaline and circulation patterns in the Western Tropical South Atlantic Ocean | |
Josephson et al. | Association between emigration and age structure in populations of brook trout (Salvelinus fontinalis) in Adirondack lakes | |
TWM630290U (en) | Ditch cover structure for preventing odor and mosquitoes | |
Vicente et al. | Observations on Pyxidium tardigradum (Ciliophora), a protozoan living on Eutardigrada: infestation, morphology and feeding behaviour | |
Cassis et al. | Phylogenetic reclassification and genitalic morphology of the small water strider genus Nesidovelia Andersen & Weir and allied Microveliinae (Hemiptera: Veliidae) | |
Koutsogiannopoulou et al. | The fish assemblage of the intertidal salt marsh creeks in North Bull Island, Dublin Bay: seasonal and tidal changes in composition, distribution and abundance | |
Truong et al. | Testicular development, reproducing references and length at first maturity of Acentrogobius viridipunctatus (Actinopteri: Gobiiformes) in the southwest Viet Nam | |
Banerjee et al. | Parasitic infections in some wild animals of Uttaranchal | |
LeDuc et al. | Certified cell lines of rat origin appear free of infection with Hantavirus | |
Meyer et al. | Mayflies (Ephemeroptera) of the far western United States. Part 2: Oregon | |
Alvarez et al. | Observations of atypical habitat use by Foothill Yellow-legged Frogs (Rana boylii) in the Coast Range of California | |
Smith et al. | Isolation of primate calicivirus Pan paniscus type 1 from a douc langur (Pygathrix nemaeus l.) | |
Schalk et al. | Summer microhabitat use of the Greater Siren (Siren lacertina) and Two-toed Amphiuma (Amphiuma means) in an isolated wetland | |
Lane et al. | Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteriainfection and gastritis | |
Biswal et al. | Temporal variation of the cestode, Cotugnia cuneata (Meggit, 1924) in their host, domestic pigeons, Columba livia domestica (Gmelin, 1789) | |
Orfinger | Redescription and Transfer of Holocentropus timesis (Denning) New Combination (Trichoptera: Polycentropodidae) | |
CN2402247Y (en) | Movable environment protection comfort station | |
ZHAO et al. | Study on bio-processes in desertification in northern agro-pasture interzone | |
Muths | An observation on caching of prey by a long-tailed weasel (Mustela frenata) | |
Benedek et al. | Correlation between diet and breeding of Tyto alba (Scopoli, 1769)(Aves: Tytonidae) |